• Explore /
  • Poster
  • / A phase Ib study of IMU-131 HER2/neu peptide vaccine plus chemotherapy in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction.

A phase Ib study of IMU-131 HER2/neu peptide vaccine plus chemotherapy in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction.

Abstract Poster

Authors

null

Yee Chao

Taipei Veterans General Hospital, Taipei, Taiwan

Yee Chao , Thomas Yau , Marina Maglakelidze , Iurie Bulat , Suebpong Tanasanvimon , Chaiyut Charoentum , Wichit Arpornwirat , Jedzada Maneechavakajorn , Arunee Dechaphunkul , Teerapat Ungtrakul , Chia-Jui Yen , Li-Yuan Bai , Wen-Chi Chou , Ursula Wiedermann , Anthony J Good , Nick Ede , Leslie Mi Ok Chong

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

NCT02795988

Citation

J Clin Oncol 37, 2019 (suppl; abstr 4030)

DOI

10.1200/JCO.2019.37.15_suppl.4030

Abstract #

4030

Poster Bd #

135

Abstract Disclosures

Similar Posters

First Author: Ursula Wiedermann

First Author: Josep Tabernero

First Author: Yung-Jue Bang

First Author: Josep Tabernero